ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 821

Association of Serum Uric Acid and Incident Fractures in Elderly Men

Nancy E. Lane1, Neeta Parimi2, Barton Wise3, Peggy Cawthon4, Eric Orwoll5 and MrOS Investigators Group6, 1Internal Medicine, Center for Musculoskeletal Health, UC Davis School of Medicine, Sacramento, CA, 2Clinical Research, CPMC Research Institute, SF, CA, 3Int Medicine, UC Davis, School of Medicine, Sacramento, CA, 4Clinical Research, CPMC Research Institute, San Francisco, CA, 5Int Medicine, Portland, OR, 6Sacramento, CA

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: fractures, osteoporosis and uric acid

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Osteoporosis and Metabolic Bone Disease

Session Type: Abstract Submissions (ACR)

Background/Purpose: Normal mineral metabolism is critical for skeletal integrity.  Uric acid (UA) is produced from purines by the enzyme xanthine oxidase, and elevated levels may cause gouty arthritis and kidney stones. High uric acid levels result in endothelial damage and play a role in disease processes including hypertension, heart failure and renal disease.  Conversely, UA also appears to function as an anti-oxidant and may protect against the oxidative stress associated with aging and disease.  Recently, serum uric acid was reported associated with elevated bone mineral density and lower prevalence of fractures in older men (Nabipour, JBMR 2011).  To confirm this association, we performed a prospective case-cohort study to understand the relation of uric acid and fracture risk in older men enrolled in the Osteoporotic Fractures in Men (MrOS) study.

Methods:  In the cohort of 5994 men 65 and older attending the baseline MrOS examination, we evaluated a subgroup 1,682 men in a case-cohort study design. This group included 387 men with incident non-vertebral fractures (with 73 hip fractures) and a sample of 1385 men randomly selected from the cohort with baseline mineral and calcium hormone measurements.  Serum uric acid was measured in baseline serum samples by Unical DxC 800 auto-analyser (Beckman Coulter, Fullerton, CA, USA).  All men who experienced any non-vertebral fracture from baseline until February 2007 (average follow-up 4.7 years) were included in the analysis.  Incident fractures were confirmed with x-ray reports.  Hip bone mineral density was obtained at the baseline.   Modified proportional hazards models that account for case-cohort study design were used to estimate the relative hazards (RH) of fracture in men for serum uric acid.

Results: Subjects with incident non-vertebral fractures were older, had lower total hip BMD, and higher serum phosphorus. Cases were more likely to report a history of falls and to be frail (all p<0.01).  Overall, there was no difference in risk of hip fracture by baseline uric acid after adjustment for age, clinic site, BMI, race, total hip BMD, vitamin D and PTH.   However, there is 19% decrease risk of non-vertebral fractures (95% CI 0.71-0.93; p=0.003) per 1 SD increase of baseline UA after multivariate adjustment.  Total hip BMD was significantly higher in the group of men with high uric acid levels and increased continuously across quartiles of uric acid after multivariate adjustment (p for trend=0.009).

Conclusion: Higher serum uric acid levels were associated with a reduction in risk of incident fractures and higher hip bone mineral density.


Disclosure:

N. E. Lane,
None;

N. Parimi,
None;

B. Wise,
None;

P. Cawthon,
None;

E. Orwoll,
None;

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/association-of-serum-uric-acid-and-incident-fractures-in-elderly-men/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology